family. CDK8 activates or represses transcription by associating with the mediator complex
or by regulating transcription factors. Oncogenic activity of CDK8 has been demonstrated in
several cancer types. Targeting CDK8 represents a potential therapeutic strategy. Because
knockdown of CDK8 in a natural killer (NK) cell line enhances cytotoxicity and NK cells
provide the first line of immune defense against transformed cells, we asked whether …